Smoking Clinical Trial - Promoting Tobacco Control & Smoking Cessation in

Status Recruiting

Clinical Trial Summary

Previous research shows a significant proportion of smokers work in full-time employment. Given that the majority of smokers do not aware of the smoking cessation services available in Hong Kong, implementing smoking cessation policy in the workplaces may assist a considerable number of smokers to stop or reduce smoking.

This study aims to:

1. examine the employers' knowledge, attitudes and practices in promoting smoking cessation in workplace.

2. test the effectiveness of a brief and an intensive smoking cessation interventions to help workers stop smoking

In Phase I of this study, a large scale cross-sectional survey will be conducted to 3000 corporate companies in Hong Kong. The questionnaire will examine the employers' knowledge, attitudes and practices in promoting smoking cessation in the workplaces.

In Phase II, a longitudinal study will be conducted to evaluate the effectiveness of a smoking cessation intervention offered by the Department of Psychology, the University of Hong Kong. Smokers from the participating companies will be interviewed before the intervention at baseline, immediately after the intervention, and at 1-, 4-, 12-, 26- and 52-week post-intervention follow-ups.

The follow-up assessments will consist of a biochemical validation for the self-reported quitters who report quitting in the past 7 days via exhaled carbon monoxide and saliva cotinine concentration tests. Participants' smoking behaviour, knowledge on smoking and satisfaction of the smoking cessation services will also be evaluated.

It is hypothesized that the smoking cessation intervention helps workers stop smoking. Employers' knowledge and attitudes are positively associated with the practices in promoting smoking cessation in workplace.

Process evaluation: Qualitative interviews, including in-depth interviews and/or focus group will be conducted after 6-month follow-up.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Smoking

Clinical Trial Details

NCT number	NCT02179424
Study type	Interventional
Source	The University of Hong Kong
Contact	Tai Hing Lam, MD
Phone	+852 2819 9287
Email	hrmrlth@hku.hk
Status	Recruiting
Phase	N/A
Start date	December 2012
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03999411` - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients	Phase 4
Completed	`NCT03931772` - Online Automated Self-Hypnosis Program	N/A
Completed	`NCT02649556` - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2	N/A
Completed	`NCT03901066` - Smoking Dependence and Periodontitis
Recruiting	`NCT05846841` - Personalized Tobacco Treatment in Primary Care (MOTIVATE)	N/A
Completed	`NCT03170752` - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)	N/A
Completed	`NCT03305978` - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.	N/A
Completed	`NCT00000437` - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)	Phase 4
Completed	`NCT06105424` - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability	N/A
Active, not recruiting	`NCT02752022` - Monitoring the Transition From Smoking to E-cigarettes
Completed	`NCT04340830` - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants	N/A
Completed	`NCT03206619` - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed	`NCT02901171` - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation	N/A
Completed	`NCT02912000` - TEACH: Technology Evaluation to Address Child Health	N/A
Completed	`NCT02949648` - Electronic Cigarette Use and Quitting in Youth	N/A
Completed	`NCT02945371` - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life	N/A
Completed	`NCT02246114` - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women	N/A
Completed	`NCT03448900` - Intervention Study for Smoking Cessation in Spanish College Students	N/A
Completed	`NCT02008292` - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors	N/A
Completed	`NCT01898507` - Nicotine Metabolism and Low Nicotine Cigarettes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Promoting Tobacco Control and Smoking Cessation in Workplaces

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms